{"id":"W4296007234","doi":"10.1016/j.annonc.2022.07.1017","title":"891P Naxitamab treatment for relapsed or refractory high-risk neuroblastoma: Outcomes from the first prespecified analyses of the Pivotal 201 Trial","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"Y-mAbs Therapeutics","keywords":"Medicine; Refractory (planetary science); Internal medicine; Population; Post-hoc analysis; Clinical endpoint; Neuroblastoma; Phases of clinical research; Clinical trial; Surgery; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003131541,0.001027644,0.001679929,0.0001978172,0.0003639997,0.00174767,0.0005891044,0.0007732338,0.002658402],"category_scores_gemma":[0.003594948,0.0003480507,0.002648243,0.0004974403,0.0006195454,0.001153822,0.0006116329,0.00233389,0.0006771697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001884434,"about_ca_system_score_gemma":0.001906915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00136047,"about_ca_topic_score_gemma":0.00674698,"domain_scores_codex":[0.998389,0.0008147742,0.00008164106,0.0002715505,0.0001822822,0.0002607198],"domain_scores_gemma":[0.9976054,0.0008182601,0.0006119066,0.000306939,0.0002537015,0.0004038387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7467657,0.001765119,0.0580462,0.002723718,0.01665411,0.0005203625,0.0003049054,0.005240256,0.0135305,0.001673258,0.0280853,0.1246905],"study_design_scores_gemma":[0.3886074,0.1311876,0.342925,0.001799155,0.0372394,0.002985136,0.0008016699,0.005783307,0.01001236,0.008916382,0.06932133,0.0004210904],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9658753,0.01286461,0.0007260614,0.002262713,0.0004897268,0.0004282092,0.008392174,0.00007484082,0.008886309],"genre_scores_gemma":[0.9761564,0.003875052,0.0006894916,0.001477564,0.0002726187,0.0002769293,0.01489976,0.00006938043,0.00228272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003131541,"threshold_uncertainty_score":0.01656133,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2353686009104677,"score_gpt":0.4422416962645087,"score_spread":0.206873095354041,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}